Abstract
Objectives: To evaluate the effectiveness of cardiac resynchronization therapy (CRT) in the treatment of patients with severe heart failure. Methods and design: from February, 2011 to February 2014, 51 patients with severe left ventricular systolic dysfunction were received CRT based on indications of ACC/AHA/HRS recommendations 2008. Data of clinical presentations, electrocardiograms, echocardiography, biochemical tests were obtained before CRT implantation and just after, 1 month, 6 month and 12 month after implantation. Result: 51 patients with average ages of 55 ± 14,7 years. 36 males (70,6%) and 15 females (29,4%). Successful rate of procedures was 98,03%. Survival rate after 12 month follow-up duration was 94%. After implantation, QRS complexes on ECG significantly reduced from 151 ± 31,7 to 134,48 ± 20,08 ms (p < 0,001). After follow-up duration, there was significant reduction in NYHA function class, left ventricular end diastolic/systolic diameters, mitral regurgitation level, systolic pulmonary pressure, NT-proBNP concentrations (p < 0,05). Theres was also a significant increase of left ventricular ejection fraction (p < 0,05). Conclusion: Cardiac resynchronization therapy has a technical successful rate of 98,03%. Survival rate after 12 month was 94%. CRT significantly improves NYHA function class, reduces QRS complex duration, reduces left ventricular size, increases left ventricular ejection fraction, reduces mitral regurgitation level, reduces systolic pulmonary pressure, reduces NT-proBNP concentration.